Eric Drapé
Chief Operating Officer at TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Net worth: 2 M $ as of 2024-03-30
Profile
Currently, Eric Drapé occupies the position of Executive Vice President-Global Operations at Teva Pharmaceutical Industries Ltd. He is also on the board of Laboratoire Français Du Fractionnement et Biotechnologies and Ipsen Manufacturing Ireland Ltd. He previously occupied the position of Executive Vice President & Head-Quality at Teva Pharmaceutical Industries Ltd., Executive Vice President-Technical Operations at Ipsen SA and Executive Vice President-Technical Operations at Ipsen Pharma SAS (a subsidiary of Ipsen SA), Chairman for Beaufour Ipsen Industrie SAS and Senior Vice President-Diabetes Finished Products at Novo Nordisk SAS. He received an MBA from Scandinavian International Management Institute and a doctorate from Université de Paris XI Paris Sud.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-04 | 145,915 ( 0.01% ) | 2 M $ | 2024-03-30 |
Eric Drapé active positions
| Companies | Position | Start |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Chief Operating Officer | 2019-10-01 |
Ipsen Manufacturing Ireland Ltd.
 Ipsen Manufacturing Ireland Ltd. BiotechnologyHealth Technology Ipsen Manufacturing Ireland Ltd. operates as a biopharmaceutical group dedicated to improving lives through innovative medicines. The company was founded in 1989 and is headquartered in Dublin, Ireland. | Director/Board Member | - |
Laboratoire Français du Fractionnement et des Biotechnologies
 Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | Director/Board Member | - |
Former positions of Eric Drapé
| Companies | Position | End |
|---|---|---|
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Corporate Officer/Principal | 2013-06-30 |
Beaufour Ipsen Industrie SAS
 Beaufour Ipsen Industrie SAS Medical DistributorsDistribution Services Beaufour Ipsen Industrie SAS manufactures pharmaceutical products. The company was founded on July 22, 1942 and is headquartered in Dreux, France. | Chairman | - |
Ipsen Biopharm Ltd.
 Ipsen Biopharm Ltd. Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Ipsen Biopharm Ltd. is a British biopharmaceutical company that aims to prolong patients' lives, improve health outcomes, and create a positive impact for patients and society. Founded in 1982, the private company is based in Wrexham, UK. Ipsen specializes in the fields of oncology, neuroscience, and rare disease, and creates and manufactures pharmaceutical products to improve patients' lives through research and innovation. | Director/Board Member | - |
Novo Nordisk SAS
 Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France. | Corporate Officer/Principal | - |
| IPSEN | Corporate Officer/Principal | - |
Training of Eric Drapé
| Scandinavian International Management Institute | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| IPSEN | Health Technology |
| Private companies | 7 |
|---|---|
| Université de Paris XI Paris Sud | Consumer Services |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | Health Technology |
Novo Nordisk SAS
Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France. | Health Technology |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
Beaufour Ipsen Industrie SAS
Beaufour Ipsen Industrie SAS Medical DistributorsDistribution Services Beaufour Ipsen Industrie SAS manufactures pharmaceutical products. The company was founded on July 22, 1942 and is headquartered in Dreux, France. | Distribution Services |
Ipsen Biopharm Ltd.
Ipsen Biopharm Ltd. Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Ipsen Biopharm Ltd. is a British biopharmaceutical company that aims to prolong patients' lives, improve health outcomes, and create a positive impact for patients and society. Founded in 1982, the private company is based in Wrexham, UK. Ipsen specializes in the fields of oncology, neuroscience, and rare disease, and creates and manufactures pharmaceutical products to improve patients' lives through research and innovation. | Health Technology |
Ipsen Manufacturing Ireland Ltd.
Ipsen Manufacturing Ireland Ltd. BiotechnologyHealth Technology Ipsen Manufacturing Ireland Ltd. operates as a biopharmaceutical group dedicated to improving lives through innovative medicines. The company was founded in 1989 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Eric Drapé
